17. Multiple system atrophy Clinical trials / Disease details

Clinical trials : 118 / Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02591173 (ClinicalTrials.gov)	February 2016	27/10/2015	Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure	Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure	Autonomic Nervous System Disorders;Pure Autonomic Failure;Shy-Drager Syndrome;Orthostatic Hypotension, Dysautonomic	Drug: Angiotensin -(1-7);Drug: Saline	Vanderbilt University Medical Center	NULL	Terminated	18 Years	80 Years	All	7	Early Phase 1	United States
2	NCT01119417 (ClinicalTrials.gov)	May 2010	4/5/2010	The Role of Endothelin in the Supine Hypertension of Autonomic Failure	The Role of Endothelin in the Supine Hypertension of Autonomic Failure	Hypertension;Pure Autonomic Failure;Multiple System Atrophy	Drug: BQ123;Drug: Bq123;Drug: Saline	Vanderbilt University	NULL	Withdrawn	18 Years	85 Years	All	0	Phase 1	United States
3	NCT00911365 (ClinicalTrials.gov)	May 2008	26/5/2009	Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy	A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy	Multiple System Atrophy	Biological: autologous mesenchymal stem cells;Biological: normal saline	Yonsei University	NULL	Completed	N/A	75 Years	Both	27	Phase 2	Korea, Republic of